Stock Ratings / Health Care / TCMD / options

SGHT (38) MDXG (77) ANGO (50) RCEL (44) ⌘ Pro Terminal →

Tactile Systems Technology Inc. (TCMD) Options Positioning, Max Pain & Unusual Sweeps

$24.31 +1.67% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Tactile Systems Technology Inc. (TCMD) earns a Roarable Rating of B+ (Buy) with 78/100 RQD Confidence. High-quality cash engine (76% profit margin, 17% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B+ • BUY Cap $550.7M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B+

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk A-

Each axis scored 0–20

12M PRICE TARGET CONE+9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for TCMD)Realized 20D OHLCV Swing Band: ±6.1%

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±6.1%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (TCMD)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for TCMD.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating TCMD & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on TCMD
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

TCMD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +5.60%▲ ASCENDING CHANNEL

2026-10-30O $24.32H $24.34L $22.85C $24.31VOL 210.7K

RES: $33.37SUP: $21.82SMA50: $22.74SMA200: $25.87

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TCMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 TCMD Butterfly Map → + Track TCMD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

22.2%/yr Implied 5Y Growth

vs. +12.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on TCMD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TCMD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for TCMD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (TCMD)

Health Care Rank #23 of 1016 ⚔️ SGHT vs TCMD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (TCMD vs. SGHT, MDXG, ANGO, RCEL)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Tactile Systems Technology Inc. (TCMD) ranks #23 by composite RQD confidence (78/100, grade B+) and #431 by equity capitalization ($550.7M). Within this direct 5-issuer industry benchmark cohort, MDXG leads on earnings valuation at 11.9x trailing P/E, while MDXG leads on capital efficiency and profitability with 47.2% ROIC and 82.6% gross margin. TCMD currently leads its immediate peer cohort in composite quantitative strength at 78/100 (B+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
TCMD ACTIVE Tactile Systems Technology Inc.	B+	78/100	28.9x	75.9%	17.1%	+1.67%	$550.7M	Benchmark Subject
SGHT Sight Sciences Inc.	D-	38/100	—	86.2%	-35.0%	+3.57%	$527.2M	/sght-vs-tcmd →
MDXG MiMedx Group Inc	B+	77/100	11.9x	82.6%	47.2%	+0.51%	$579.3M	/mdxg-vs-tcmd →
ANGO AngioDynamics Inc.	D	50/100	—	54.6%	-23.4%	+1.81%	$519.4M	/ango-vs-tcmd →
RCEL Avita Medical Inc.	D	44/100	—	82.1%	-35.0%	+1.27%	$516.8M	/rcel-vs-tcmd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001027838

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Tactile Systems Technology Inc. (TCMD) reported GAAP revenue of $329.5M (+12.5% vs. FY2024 revenue of $293.0M , and +20.1% cumulative change since FY2023) , GAAP net income of $19.1M, operating cash flow of $42.8M, and free cash flow of $40.4M (+5.7% YoY). On the balance sheet, TCMD closed FY2025 with $273.9M in total assets against $0 in total debt (Altman Z-Score: 8.38, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$329.5M	$19.1M	$42.8M	$40.4M	$273.9M	—
FY2024 (FY)	2024-12-31	$293.0M	$17.0M	$40.7M	$38.3M	$297.9M	—
FY2023 (FY)	2023-12-31	$274.4M	$28.5M	$35.9M	$35.9M	—	—

3. TCMD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is TCMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Tactile Systems Technology Inc. (NASDAQ: TCMD) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 78/100 at a spot price of $24.31 (+1.67% 1D, market cap $550.7M). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, TCMD ranks #23 in composite RQD confidence.

How does TCMD compare to SGHT and MDXG in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), TCMD carries a Roarable B+ (78/100 RQD), trailing P/E of 28.9x, gross margin of 75.9%, and ROIC of 17.1%. By comparison, SGHT (Sight Sciences Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $527.2M) and MDXG (MiMedx Group Inc) posts a B+ grade (77/100 RQD, P/E 11.9x, ROIC 47.2%, cap $579.3M). Among the 5-stock peer group, MDXG leads on earnings multiple (11.9x) while MDXG leads on capital efficiency (47.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for TCMD?

Per TCMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001027838), Tactile Systems Technology Inc. generated $329.5M in revenue (+12.5% YoY), $19.1M in net income, and $40.4M in free cash flow against $273.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (76% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is TCMD trading relative to its 50-day, 200-day, and 52-week technical levels?

TCMD last traded at $24.31 (+1.67% on volume of 157,936 shares), positioning the stock +6.90% above its 50-day simple moving average ($22.74) and -6.03% below its 200-day simple moving average ($25.87). Across its 52-week range of $15.32 to $37.77, TCMD sits at the 40.0% percentile with a 14-day RSI of 49.2 (NEUTRAL RANGE) and an implied next-earnings move of ±6.1% ($22.83 to $25.79).

TCMD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is TCMD's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for TCMD.

Direct Sub-Reports: TCMD RQD Cockpit TCMD 12M Forecast TCMD Earnings & Move TCMD Dividends & DRIP TCMD Insiders & 13F TCMD Whale Options TCMD Profit Sankey TCMD News & Why